Literature DB >> 739790

Immune proteins and other biochemical constituents of peripheral lymph in patients with malignancy and postirradiation lymphedema.

W L Olszewski, K Loe, A Engeset.   

Abstract

Concentration of immunoglobulins and complement proteins were studied in a group of 33 patients with localized tumors and lymphoproliferative disorders. Generally, low levels have been found, in many cases below the lowest limit of the control group. The reductions in concentration were more pronounced in patients with lympho-proliferative disorders than with solid tumors. The most reduced were IgM, C1g and total complement hemolytic activity. In a group of 8 patients with lymphedema of lower extremity complicating therapy for uterine cancer an increase of IgM and IgA and decrease in hemolytic activity were found. This indicates to the existence of a chronic inflammatory process, typical for tissues deprived lymphatic outflow.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 739790

Source DB:  PubMed          Journal:  Lymphology        ISSN: 0024-7766            Impact factor:   1.286


  4 in total

1.  Signaling proteins are represented in tissue fluid/lymph from soft tissues of normal human legs at concentrations different from serum.

Authors:  Marzanna Zaleska; Waldemar L Olszewski; Marek Durlik; Norman E Miller
Journal:  Lymphat Res Biol       Date:  2013-12       Impact factor: 2.589

2.  Unusual sarcoma arising in lymphoedema.

Authors:  C M Fergusson; S A Copeland; L Horton
Journal:  J R Soc Med       Date:  1985-06       Impact factor: 5.344

3.  Chronic lower limb wounds evoke systemic response of the lymphatic (immune) system.

Authors:  W L Olszewski; P Jain; M Zaleska; E Stelmach; E Swoboda
Journal:  Indian J Plast Surg       Date:  2012-05

4.  CD4(+) cells regulate fibrosis and lymphangiogenesis in response to lymphatic fluid stasis.

Authors:  Jamie C Zampell; Alan Yan; Sonia Elhadad; Tomer Avraham; Evan Weitman; Babak J Mehrara
Journal:  PLoS One       Date:  2012-11-20       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.